NCT04942873 (NVAF) is a clinical trial of adherence in Nonvalvular Atrial Fibrillation, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT04942873?

NCT04942873 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT04942873?

Interventions in NCT04942873: adherence.

What condition does NCT04942873 study?

NCT04942873 studies Nonvalvular Atrial Fibrillation.

Is NCT04942873 still recruiting?

NCT04942873 is currently status unknown. Last updated 29 June 2021.

Last reviewed 2021-06-29 · How we verify

NCT04942873: NVAF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Adherence to Oral Anticoagulant in Chinese Patients With NVAF

Status unknown Last updated 29 June 2021

What this trial tests

trial testing adherence in Nonvalvular Atrial Fibrillation in 500 participants. Status unknown.

Timeline

20 July 2021

Primary endpoint
6 June 2022

10 June 2023

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	20 July 2021
Primary completion	6 June 2022
Estimated completion	10 June 2023
Sites	1 location across China

Drugs / interventions tested

adherence

Conditions studied

Nonvalvular Atrial Fibrillation — all drugs for Nonvalvular Atrial Fibrillation →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Eligibility, any sex, with Nonvalvular Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigate the compliance of oral anticoagulants in Chinese NVAF patients and find out the causes, so as to provide basis for formulating effective measures to improve the compliance of oral anticoagulants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nonvalvular Atrial Fibrillation

Currently open trials in the same condition.

NCT07125417 — Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure · Phase 4 · recruiting

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04942873 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 29 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing